glp 1 molecular structure GLP-1 receptor agonist 2 GLP-1 Drugs: A Paradigm Shift

42.Jackson SH, Martin TS, Jones JD, Seal D, Emanuel F

The judgment in these cases reflects not only the direct harm caused but also the broader implications for patient safety and the healthcare systems duty to protect the quality of human life

M.et al (2011)

Permanent vision loss claims focus on alleged optic nerve damage and visual impairment, while gastrointestinal cases focus on delayed gastric emptying, intestinal motility problems, obstruction, and related digestive complications

The benefits on heart failure were observed in both patients with a history of heart failure (decreased 37%) and patients without a history of heart failure (decreased 21%) (161)

Retrospective cohort of 83,825 patients: 50-56% lower AUD risk over 12 months